Correlation Between Cytodyn and ImmunoGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cytodyn and ImmunoGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytodyn and ImmunoGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytodyn and ImmunoGen, you can compare the effects of market volatilities on Cytodyn and ImmunoGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytodyn with a short position of ImmunoGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytodyn and ImmunoGen.

Diversification Opportunities for Cytodyn and ImmunoGen

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cytodyn and ImmunoGen is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Cytodyn and ImmunoGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImmunoGen and Cytodyn is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytodyn are associated (or correlated) with ImmunoGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImmunoGen has no effect on the direction of Cytodyn i.e., Cytodyn and ImmunoGen go up and down completely randomly.

Pair Corralation between Cytodyn and ImmunoGen

Given the investment horizon of 90 days Cytodyn is expected to generate 104.66 times less return on investment than ImmunoGen. But when comparing it to its historical volatility, Cytodyn is 1.69 times less risky than ImmunoGen. It trades about 0.0 of its potential returns per unit of risk. ImmunoGen is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  500.00  in ImmunoGen on September 6, 2024 and sell it today you would earn a total of  1,320  from holding ImmunoGen or generate 264.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy30.36%
ValuesDaily Returns

Cytodyn  vs.  ImmunoGen

 Performance 
       Timeline  
Cytodyn 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cytodyn has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
ImmunoGen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ImmunoGen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, ImmunoGen is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Cytodyn and ImmunoGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cytodyn and ImmunoGen

The main advantage of trading using opposite Cytodyn and ImmunoGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytodyn position performs unexpectedly, ImmunoGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImmunoGen will offset losses from the drop in ImmunoGen's long position.
The idea behind Cytodyn and ImmunoGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume